Nicolas Barthelemy is of REPLIGEN CORP. Currently has a direct ownership of 4,668 shares of RGEN, which is worth approximately $685,962. The most recent transaction as insider was on Jun 14, 2024, when has been sold 1,200 shares (Common Stock) at a price of $125.45 per share, resulting in proceeds of $150,540. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.67K
0% 3M change
68.7% 12M change
Total Value Held $685,962

NICOLAS BARTHELEMY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 14 2024
BUY
Open market or private purchase
$150,540 $125.45 p/Share
1,200 Added 20.45%
4,668 Common Stock
May 16 2024
BUY
Grant, award, or other acquisition
-
701 Added 16.81%
3,468 Common Stock
May 18 2023
BUY
Grant, award, or other acquisition
-
686 Added 19.87%
2,767 Common Stock
May 26 2022
BUY
Grant, award, or other acquisition
-
534 Added 20.42%
2,081 Common Stock
Oct 29 2021
SELL
Open market or private sale
$474,089 $288.2 p/Share
1,645 Reduced 51.54%
1,547 Common Stock
Oct 29 2021
BUY
Exercise of conversion of derivative security
$164,711 $128.18 p/Share
1,285 Added 28.7%
3,192 Common Stock
May 13 2021
BUY
Grant, award, or other acquisition
-
457 Added 19.33%
1,907 Common Stock
Nov 09 2020
SELL
Open market or private sale
$237,349 $195.51 p/Share
1,214 Reduced 45.57%
1,450 Common Stock

Also insider at

MASS
908 Devices Inc. Healthcare
TWST
Twist Bioscience Corp Healthcare
LAB
STANDARD BIOTOOLS INC. Healthcare
NB

Nicolas Barthelemy

Waltham, MA

Track Institutional and Insider Activities on RGEN

Follow REPLIGEN CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGEN shares.

Notify only if

Insider Trading

Get notified when an Repligen Corp insider buys or sells RGEN shares.

Notify only if

News

Receive news related to REPLIGEN CORP

Track Activities on RGEN